SmartKem announced that it has converted approximately $2.0 million of its outstanding accounts payable into a combination of common stock and pre‑funded warrants at an implied conversion price of $2.75 per share, fully discharging the liability without any cash outlay.
The transaction reduces current liabilities and preserves cash that can be directed toward research, development, and commercialization of the company’s organic semiconductor technology. In exchange for the debt, the creditor received 385,130 shares of common stock and warrants to purchase 348,260 shares, creating a dilution effect for existing shareholders.
The conversion follows a pattern of financing activity, including a $1 million bridge financing obtained in October 2025 and a non‑binding letter of intent to acquire Carbonium Core, Inc. for $120 million in preferred stock announced in early February 2026. SmartKem’s Q3 2025 results showed revenue of $81 000 and a loss from operations of $3.1 million, highlighting the company’s short cash runway and the need for additional capital.
Management emphasized that the debt conversion is part of a broader strategy to strengthen the balance sheet and support ongoing product development. While the transaction improves liquidity, it does not eliminate the need for further capital to fund growth and address cash burn.
Investors expressed concern about the dilution of shares and the company’s persistent financial challenges, reflecting the broader context of SmartKem’s negative equity and high beta.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.